Oculis Holding AG
(NASDAQ:OCS)
$9.99
0.17 (1.68%)
At Close: 4:00 PM
OCS Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
OCS Stock Price Today
Oculis Holding AG (OCS) stock rallied over 1.75% intraday to trade at $9.87 a share on NASDAQ. The stock opened with a loss of -4.18% at $9.41 and touched an intraday high of $10.00, rising 0.51% against the last close of $9.82. The Oculis Holding AG in stock market went to a low of $9.41 during the session.
OCS Stock Snapshot
$9.82
Prev. Close
363.54 Million
Market Cap
$9.41
Day Low
$9.41
Open
N/A
Number of Shares
$10.00
Day High
N/A
P/E ratio
N/A
EPS (TTM)
2.91
Cash Flow per Share
N/A
Free Float in %
2.88
Book Value
3542.00
Volume
OCS Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta0.16
Sales or Revenue$912 Thousands
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryPharmaceuticals
About Company
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Peers
Frequently Asked Questions
What is the current Oculis Holding AG (OCS) stock price?
Oculis Holding AG (NASDAQ: OCS) stock price is $9.87 in the last trading session. During the trading session, OCS stock reached the peak price of $10.00 while $9.41 was the lowest point it dropped to. The percentage change in OCS stock occurred in the recent session was 1.75% while the dollar amount for the price change in OCS stock was $0.17.
OCS's industry and sector of operation?
The NASDAQ listed OCS is part of Pharmaceuticals industry that operates in the broader Healthcare sector. Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
Who are the executives of OCS?
Dr. Riad Sherif M.B.A., M.D.
Chief Executive Officer & Director
Mr. Weibo Ding
Global Chief Operating Officer & GM of China
Dr. Bastian Dehmel
Chief Devel. Officer & Head of Devel.
Dr. Fang Li
Sr. VP of Regulatory Affairs
How OCS did perform over past 52-week?
OCS's closing price is 1.04% higher than its 52-week low of $6.26 where as its distance from 52-week high of $14.5 is -0.09%.
How many employees does OCS have?
Number of OCS employees currently stands at N/A. OCS operates from Bahnhofstrasse 7<br/>Zug 6300<br/>Switzerland.
Link for OCS official website?
Official Website of OCS is: https://www.oculis.com
How do I contact OCS?
OCS could be contacted at phone #41 58 810 0182 and can also be accessed through its website. OCS operates from Bahnhofstrasse 7<br/>Zug 6300<br/>Switzerland.
How many shares of OCS are traded daily?
OCS stock volume for the day was 3542.00 shares. The average number of OCS shares traded daily for last 3 months was 17.36 Thousands.
What is the market cap of OCS currently?
The market value of OCS currently stands at $363.54 Million with its latest stock price at $9.87 and N/A of its shares outstanding.